Zevra Therapeutics (ZVRA) Inventory Average (2025 - 2026)
Zevra Therapeutics (ZVRA) posted Inventory Average of $2.0 million for Q1 2026, up 30.35% on a QoQ basis from $1.6 million in Q4 2025, and down 10.58% year-over-year from $2.3 million in Q1 2025.
Zevra Therapeutics (ZVRA) Inventory Average (2025 - 2026) Analysis & Trends
Zevra Therapeutics' Inventory Average history runs 2 years deep, the most recent figure standing at $2.0 million for Q1 2026.
- Quarterly Inventory Average fell 10.58% year-over-year to $2.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.0 million (down 10.58% YoY) and the FY2025 annual result came in at $1.9 million, changed N/A from the prior year.
- Inventory Average was $2.0 million for Q1 2026 at Zevra Therapeutics, up from $1.6 million in the prior quarter.
- Across five years, Inventory Average topped out at $2.3 million in Q1 2025 and bottomed at $1.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 644.91 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.73 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 3.15 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Zevra Therapeutics | 239.71 Mn | 39.10 Mn | 34.32 Mn | 2.03 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.03 Mn |
| Dec 31, 2025 | 1.55 Mn |
| Sep 30, 2025 | 1.24 Mn |
| Jun 30, 2025 | 1.83 Mn |
| Mar 31, 2025 | 2.26 Mn |